Panoramic Capital Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$501K Sell
545
-13
-2% -$13.2K 0.31% 29
2025
Q4
$600K Buy
558
+8
+1% +$7.65K 0.37% 27
2025
Q3
$420K Sell
550
-5
-0.9% -$3.72K 0.27% 34
2025
Q2
$433K Sell
555
-54
-9% -$42K 0.3% 30
2025
Q1
$442K Buy
609
+190
+45% +$158K 0.46% 25
2024
Q4
$323K Buy
+419
New +$347K 0.28% 33

Other funds holding LLY

Panoramic Capital Partners's LLY Position: Q1 2026 in Review

Panoramic Capital Partners reduced its Eli Lilly (LLY) stake by 2.3% in Q1 2026, selling an estimated $13.2K and leaving 545 shares worth $501K. The position accounts for 0.31% of the portfolio, ranked #29.

Panoramic Capital Partners first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $600K in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Panoramic Capital Partners held 545 shares of Eli Lilly worth $501K as of Q1 2026.
  • Panoramic Capital Partners sold 13 Eli Lilly shares in Q1 2026, an estimated $13.2K.
  • Eli Lilly made up 0.31% of Panoramic Capital Partners's portfolio in Q1 2026, its #29 holding.
  • Panoramic Capital Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Panoramic Capital Partners's Eli Lilly position peaked at $600K in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Panoramic Capital Partners's 13F filing for Q1 2026, filed 8 Apr 2026.